The FDA just approved a new drug to prevent HIV transmission

The Food and Drug Administration just approved a new drug that can be used as PrEP (pre-exposure prophylaxis) to prevent the transmission of HIV. PrEP is a medication regimen that has been shown to be 99% effective in preventing HIV transmission if taken daily. Up until now, the only drug approved for that use is Truvada, which was approved in 2012.

Related: PrEP users face rampant stigma & slut-shaming, study finds

On Thursday the FDA approved Descovy as a medication to prevent the transmission of HIV in men and transgender women who have sex with men. The approval did not extend to use by people assigned female at birth due to a lack of research into effectiveness in this population.

Descovy has been shown in clinical trials to be less harmful to users’ kidneys and bones than Truvada when used over a long term, and it has been shown to be as effective as Truvada in preventing the transmission of HIV.

The pharmaceutical corporation behind both of them – Gilead – is expected to…

Read full story, and more, from Source: The FDA just approved a new drug to prevent HIV transmission

Share

About Gay Today

Editor of Gay Today